OR

ORGANOIDSCIENCES LTD.

Organoid-based platforms for drug testing and regenerative therapeutics.

476040 | KO

Overview

Corporate Details

ISIN(s):
KR7476040001
LEI:
Country:
South Korea
Address:
경기도 성남시 분당구 판교로 338, 6층, 성남시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

ORGANOIDSCIENCES LTD. is a bio-innovation company specializing in advanced organoid-based technologies for drug development and regenerative medicine. The company focuses on two primary areas: developing novel regenerative therapeutics for diseases that are difficult to treat with conventional methods, and providing organoid-based evaluation platforms for the pharmaceutical industry. Its platforms offer solutions for drug efficacy and toxicity testing, novel material evaluation, and immunotherapy sensitivity analysis (Polaris Platform), serving as a sophisticated alternative to animal testing. By creating three-dimensional cell structures that replicate the function of human organs, ORGANOIDSCIENCES aims to shift the paradigm in therapeutic development and precision medicine.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.4 MB
2025-07-22 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 64.6 KB
2025-06-30 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 100.3 KB
2025-06-30 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 9.8 KB
2025-06-25 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 63.6 KB
2025-06-10 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-05-23 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 64.7 KB
2025-05-16 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 71.4 KB
2025-05-16 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 64.6 KB
2025-05-16 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 64.6 KB
2025-05-16 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 68.4 KB
2025-05-16 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 75.3 KB
2025-05-15 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 108.9 KB
2025-05-15 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-05-15 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB

Automate Your Workflow. Get a real-time feed of all ORGANOIDSCIENCES LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ORGANOIDSCIENCES LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ORGANOIDSCIENCES LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Develops AI-driven, glasses-free 3D holographic displays for the defense sector.
United States of America
M3D
MicroAd,Inc. Logo
Data-driven marketing tech providing DSP and SSP solutions for digital advertising.
Japan
9553
Microwave Chemical Co., Ltd. Logo
Innovating chemical and metal processing with an eco-friendly microwave platform.
Japan
9227
MindWalk Holdings Corp. Logo
AI-powered biotherapeutics firm offering end-to-end antibody discovery and engineering services.
United States of America
HYFT
Minerva Neurosciences, Inc. Logo
A clinical-stage biopharma developing treatments for central nervous system (CNS) diseases.
United States of America
NERV
A think tank providing research, consulting, and ICT solutions to public & private sectors.
Japan
3636
Modalis Therapeutics Corporation Logo
Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.
Japan
4883
Model Solution Co., Ltd. Logo
One-stop prototyping & low-volume production for IT, electronics, and medical hardware.
South Korea
417970
Modus Therapeutics Holding AB Logo
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden
MODTX
Moleculin Biotech, Inc. Logo
Developing therapies for hard-to-treat tumors (like AML) and viruses.
United States of America
MBRX

Talk to a Data Expert

Have a question? We'll get back to you promptly.